FUNDING, COLLABORATIONS AND SUPPORT
ASPREE is a 100% public-funded research project, awarded grants primarily from the U.S. and Australian governments.
The ASPREE project and sub-studies are made possible with funding and support from the following organisations:
- NIH (National Institutes of Health) (USA) The mission of the NIH is the pursuit of fundamental knowledge about the nature and behaviour of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability
- NHMRC (National Health and Medical Research Council of Australia) The NHMRC is Australia’s peak body for supporting health and medical research; for developing health advice for the Australian community, health professionals and governments; and for providing advice on ethical behaviour in health care and in the conduct of health and medical research
- NIA (National Institute on Aging) (USA) A branch of the NIH, the NIA leads a broad scientific effort to understand the nature of ageing and to extend the healthy, active years of life
- NCI (National Cancer Institute) (USA) A branch of the NIH, the NCI is a principal agency that supports cancer research and training in the USA and internationally
- NEI (National Eye Institute (USA) A branch of the NIH, the NEI is a principal agency supporting research into sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life
- VCA (Victorian Cancer Agency) (Australia) Funded by the Victorian Government, the VCA invests in projects and initiatives that rapidly translate research into treatments and approaches that will improve clinical practice and care of cancer patients
- Monash University is an energetic and dynamic university, committed to quality education and research
- CSIRO (Commonwealth Scientific and Industrial Research Organisation) is Australia’s national science agency and one of the largest and most diverse research agencies in the world
- In-kind support by Bayer Pharma (Germany) through provision of study medication and matching placebo tablet for the duration of the ASPREE clinical trial
- Walter Cottman Endowment Fund has been established for the benefit of the Faculties of Medicine at Monash University and Melbourne University
- The JO & JR Wicking Trust and Mason Foundation seek to achieve enduring, positive impact in the areas of vision impairment, care of the aged, problems associated with ageing and Alzheimer’s disease
- Phyllis Connor Memorial Trust managed by Norman Bourke and Equity Trustees
- The Jack Brockhoff Foundation exists to support the health and well-being of all Victorians
- Deafness Foundation is dedicated to the support of the Deaf and hearing impaired through research, prevention, education, early detection and technology
- Monash University, established in Melbourne in 1958, is Australia’s largest university, with a long history of excellence and impact in health sciences, with our research breakthroughs changing millions of lives for the better
- The Menzies Institute for Medical Research (Tasmania) conducts innovative, world-class medical research to improve human health and well-being
- Australian National University strives to advance the cause of learning and research in Australia and take its place amongst the great universities of the world
- The University of Adelaide, established in 1874, is Australia’s third oldest university with a strong reputation for research and teaching excellence, and producing graduates that make an impact on the world ‒ Life Impact
- Berman Center for Outcomes and Clinical Research, a division of the Hennepin Healthcare Research Institute (HHRI), has been a leader in cardiovascular research and a clinical site for over 100 trials in heart and kidney disease, diabetes, women’s health, cancer, and neurological disorders since 1965
- Foundation for Atlanta Veterans Education and Research (FAVER) / Atlanta VA Health Care System/ Emory University FAVER serves Georgia’s veterans by enabling and supporting partnerships in research and education between the Atlanta Veterans Affairs Health Care System, academic institutions, government research organisations and private companies
- Massachusetts General Hospital (MGH)/Harvard, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation
- Rush University Medical Center has for more than 170 years, led the way in developing innovative and often life-saving treatments. Today, Rush is a thriving centre for basic and clinical research, with physicians and scientists involved in hundreds of research projects developing and testing the effectiveness and safety of new therapies and medical devices.
- University of Iowa, Department of Pharmacy Practice and Science and Department of Family Medicine is one of the country’s foremost public research institutions, with support for high-impact, pioneering research at the core of our mission
Individual, Practice, Organisation and Agency Support
In addition to GPs, the ASPREE project team would like to acknowledge the assistance of medical practice staff, specialist health care providers, hospitals, pathology centres, ACAS, CDAMs clinics, aged care facilities, clinical quality registries and government departments, such as Coroners Courts and Births Deaths and Marriages across Australian states and territories, and the support of the AIHW and Services Australia, that help the study to achieve its objectives.
Other supporters of the ASPREE project include:
- SWARH (South West Alliance of Rural Health)- is an alliance connecting public hospitals and associated health services across 60,000 square kms from the west of Melbourne to the South Australian border
- RMIT– is a global university of technology and design and Australia’s largest tertiary institution. The University enjoys an international reputation for excellence in professional and vocational education and outcome-orientated research
- IHMRI (Illawarra Health and Medical Research Institute) – is a joint initiative of the University of Wollongong and Illawarra Shoalhaven Local Health District. IHMRI provides research leadership, co-ordination, infrastructure, facilities and other support to more than 500 researchers in the area
- The National Heart Foundation of Australia (NHF) letter of support for the ASPREE Clinical Trial
- The Australian General Practice Network
- Baker IDI Heart and Diabetes Institute Prof. Garry Jennings’ letter of support for the ASPREE Clinical Trial
- Jean Hailes Foundation – JHF letter of support for ASPREE
- The National Stroke Foundation
- Dementia Australia
- Australian Clinical Trials Alliance
Page updated: 1 March 2021
A new analysis of ASPREE trial data has found that prolonged daily aspirin use increases the risk of anaemia in some older adults. Findings from ASPREE-Anaemia, a sub-study of the ASPREE trial, may help GPs identify older patients at higher risk of anaemia and who may benefit from regular monitoring for development of the condition.
Walking speed and grip strength could be early indicators of dementia before the onset of noticeable symptoms, new findings from the ASPREE trial reveals. Researchers found slow walking speed combined with weak hand grip was a stronger predictor of cognitive decline and dementia in older adults than either measure alone.
A post with links to more information about studies summarised in the latest ‘TABLET’ (Winter_Spring 2022) participant newsletter.